News | January 15, 2009

Philips, Bard Develop New Tools to Treat Heart Rhythm Disorders

January 16, 2009 – As EP procedure volume increases worldwide, clinicians are requesting intuitive, advanced tools to help shorten procedure times and gain detailed visualizations for interventions, which inspired Royal Philips Electronics to sign an agreement with Bard Electrophysiology, a division of C. R. Bard Inc., to co-develop new clinical tools to help electrophysiologists.

The goal of the combination of Bard’s LabSystem PRO EP Recording System and Philips’ EP navigator and the Allura Xper FD series is to provide electrophysiologists a faster and easier way to integrate image guidance with mapping and analysis of complex arrhythmias, while offering insights for more accurate interventional navigation. EP physicians and lab staff may also benefit from improved workflow in the EP lab due to integration and compatibility between Philips and Bard technologies.

“Providing simpler and more intuitive approaches to the management of complex arrhythmias is something that fascinates me,” said Michael V. Orlov, M.D., Ph.D., director of arrhythmia service at Caritas St. Elizabeth’s Medical Center of Boston and an associate professor of Medicine at Tufts University School of Medicine. “Significant advancement in science and technology is frequently made when two seemingly dissimilar techniques are merged. The collaboration between Bard Electrophysiology and Philips is very promising, and I am looking forward to learning more about the potential for these new technologies in my practice,"

Bard said the alliance will provide alternatives to current solutions that are complex and time consuming. The two companies hope to create new, simpler approaches to these clinical challenges, expand functionality and improve efficiencies.

Bard offers advanced RF ablation and mapping catheters, diagnostic catheters, EP recording systems and stimulators, and intracardiac access products.

For more information: www.philips.com, www.bardep.com


Related Content

News | EP Lab

July 31, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home July 31, 2024
Home
News | EP Lab

July 17, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home July 17, 2024
Home
News | EP Lab

May 30, 2024 — Stereotaxis, a pioneer in surgical robotics for minimally invasive endovascular intervention, announced ...

Home May 30, 2024
Home
News | EP Lab

May 21, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home May 21, 2024
Home
News | EP Lab

February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 ...

Home February 02, 2024
Home
News | EP Lab

January 11, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of ...

Home January 11, 2024
Home
News | EP Lab

September 22, 2023 — Innovative Health, Inc. launched a new educational initiative and free online tool to help hospital ...

Home September 22, 2023
Home
News | EP Lab

August 17, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home August 17, 2023
Home
News | EP Lab

March 28, 2023 — CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...

Home March 28, 2023
Home
Subscribe Now